The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Open accessAbstract
cAMP and cGMP mediate biological responses initiated by diverse extracellular signals. By catalyzing hydrolysis of the 3′-5′-phosphodiester bond of cyclic nucleotides, cyclic nucleotide phosphodiesterases (PDEs) 1The abbreviations used are: PDEphosphodiesteraseHSLhormone-sensitive lipasePDE3IKPDE3B insulin-sensitive kinasePI3-Kphosphatidylinositol 3-kinaseIRS-1insulin receptor substrate-1. regulate intracellular concentrations and effects of these second messengers. PDEs include a large group of structurally related enzymes (reviewed in 1Manganiello V.C. Murata T. Taira M. Belfrage P. Degerman E. Arch. Biochem. Biophys. 1995; 322: 1-13Crossref PubMed Scopus (223) Google Scholar, 2Conti M. Nemos G. Sette C. Vicini E. Endocr. Rev. 1995; 16: 370-389Crossref PubMed Scopus (317) Google Scholar, 3Beavo J. Physiol. Rev. 1995; 75: 725-748Crossref PubMed Scopus (1647) Google Scholar). These enzymes belong to at least seven related gene families (PDEs 1-7) (Fig. 1), which differ in their primary structures, affinities for cAMP and cGMP, responses to specific effectors, sensitivities to specific inhibitors, and mechanisms of regulation (1Manganiello V.C. Murata T. Taira M. Belfrage P. Degerman E. Arch. Biochem. Biophys. 1995; 322: 1-13Crossref PubMed Scopus (223) Google Scholar, 2Conti M. Nemos G. Sette C. Vicini E. Endocr. Rev. 1995; 16: 370-389Crossref PubMed Scopus (317) Google Scholar, 3Beavo J. Physiol. Rev. 1995; 75: 725-748Crossref PubMed Scopus (1647) Google Scholar). Most families are comprised of more than one gene; 14 different PDE genes have been identified. Within different families, tissue-specific mRNAs are generated from the same gene by the use of different transcription initiation sites or by alternative mRNA splicing. Although some aspects of different PDE families will be discussed, this review emphasizes the PDE3 family, including structure-function information and regulation of the adipocyte PDE3, which plays a key role in the antilipolytic action of insulin. phosphodiesterase hormone-sensitive lipase PDE3B insulin-sensitive kinase phosphatidylinositol 3-kinase insulin receptor substrate-1. Mammalian PDEs share a common structural organization, with a conserved catalytic core (∼270 amino acids) usually located in the C-terminal half (Fig. 1) (4Charbonneau H. Beier N. Walsh K.A. Beavo J.A. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 9308-9312Crossref PubMed Scopus (112) Google Scholar). This region is much more similar within an individual PDE family (>80% amino acid identity) than between different PDE families (∼25-40% identity) (1Manganiello V.C. Murata T. Taira M. Belfrage P. Degerman E. Arch. Biochem. Biophys. 1995; 322: 1-13Crossref PubMed Scopus (223) Google Scholar, 2Conti M. Nemos G. Sette C. Vicini E. Endocr. Rev. 1995; 16: 370-389Crossref PubMed Scopus (317) Google Scholar, 3Beavo J. Physiol. Rev. 1995; 75: 725-748Crossref PubMed Scopus (1647) Google Scholar, 4Charbonneau H. Beier N. Walsh K.A. Beavo J.A. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 9308-9312Crossref PubMed Scopus (112) Google Scholar). The catalytic core is thought to contain common structural elements important for hydrolysis of the cyclic nucleotide phosphodiester bond, as well as family-specific determinants responsible for differences in substrate affinities and inhibitor sensitivities among the different gene families. It contains a PDE-specific sequence motif, HD(X)2H(X4)N, and two consensus Zn2+-binding domains, the second of which overlaps the PDE motif (3Beavo J. Physiol. Rev. 1995; 75: 725-748Crossref PubMed Scopus (1647) Google Scholar, 5Francis S.H. Colbran J.L. McAllister-Lucas L.M. Corbin J.D. J. Biol. Chem. 1994; 269: 22477-22480Abstract Full Text PDF PubMed Google Scholar). PDE5 contains tightly bound Zn2+, which supports catalytic activity (5Francis S.H. Colbran J.L. McAllister-Lucas L.M. Corbin J.D. J. Biol. Chem. 1994; 269: 22477-22480Abstract Full Text PDF PubMed Google Scholar). The precise role of Zn2+ or other divalent cations in catalytic function of other PDEs has not been defined. Mutagenesis of the first histidine of the PDE sequence motif abolished activity of a recombinant PDE4 expressed in Escherichia coli (6Jin S.-L. Swinnen J.V. Conti M. J. Biol. Chem. 1992; 267: 18929-18939Abstract Full Text PDF PubMed Google Scholar). Histidine- and sulfhydryl-modifying reagents inhibited PDE3 activity (7Omburo G.A. Brickus T. Ghazaleh F. Colman R.W. Arch. Biochem. Biophys. 1995; 323: 1-5Crossref PubMed Scopus (25) Google Scholar). The widely divergent N-terminal portions of PDEs (Fig. 1) contain determinants that confer regulatory properties specific to the different gene families, e.g. calmodulin-binding domains (PDE1); two non-catalytic cyclic nucleotide-binding domains (PDEs 2, 5, and 6); N-terminal membrane-targeting (PDE4) or hydrophobic membrane-association (PDE3) domains; and calmodulin (PDE1)-, cyclic AMP (PDEs 1, 3, and 4)-, and cGMP (PDE5)-dependent protein kinase phosphorylation sites, etc. (Fig
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Beavo, J. A., & Reifsnyder, D. H. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90066-h · Cited by 849
Association of Protein Kinase A and Protein Phosphatase 2B with a Common Anchoring Protein
Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M., & Scott, J. D. (1995) · Science · doi:10.1126/science.7528941 · Cited by 617
Jurevicius, J., & Fischmeister, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.295 · Cited by 373
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
Sevetson, B. R., Kong, X., & Lawrence, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10305 · Cited by 371
Maurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells.
Frödin, M., Peraldi, P., & Van Obberghen, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37589-0 · Cited by 320
Recent Progress in Understanding the Hormonal Regulation of Phosphodiesterases
Conti, M., Némoz, G., Sette, C., & Vicini, E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-370 · Cited by 312
Weishaar, R. E., Cain, M. H., & Bristol, J. A. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm50001a001 · Cited by 248
Cited by
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Guanylate cyclase and the ⋅NO/cGMP signaling pathway
Denninger, J. W., & Marletta, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00024-9 · Cited by 1,040
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A
TASKÉN, K., & AANDAHL, E. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00021.2003 · Cited by 775
Cyclic nucleotide phosphodiesterases: Relating structure and function
Francis, S. H., Turko, I. V., & Corbin, J. D. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65001-8 · Cited by 564
Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 564
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil
Corbin, J. D., & Francis, S. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13729 · Cited by 531
Nagendran, J., Archer, S. L., Soliman, D., Gurtu, V., Moudgil, R., Haromy, A., St. Aubin, C., Webster, L., Rebeyka, I. M., Ross, D. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655266 · Cited by 530
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
Rybalkin, S. D., Yan, C., Bornfeldt, K. E., & Beavo, J. A. (2003) · Circulation Research · doi:10.1161/01.res.0000087541.15600.2b · Cited by 511
Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., et al. (1999) · Circulation · doi:10.1161/01.cir.99.1.168 · Cited by 497
Use of sildenafil (Viagra) in patients with cardiovascular disease
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00656-1 · Cited by 450
An Autocrine Lactate Loop Mediates Insulin-Dependent Inhibition of Lipolysis through GPR81
Ahmed, K., Tunaru, S., Tang, C., Müller, M., Gille, A., Sassmann, A., Hanson, J., & Offermanns, S. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.012 · Cited by 440
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Signalling Mechanisms Regulating Lipolysis
Carmen, G.-Y., & Víctor, S.-M. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.009 · Cited by 429
Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry
Fukao, T., Lopaschuk, G. D., & Mitchell, G. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.11.001 · Cited by 393
Mongillo, M., McSorley, T., Evellin, S., Sood, A., Lissandron, V., Terrin, A., Huston, E., Hannawacker, A., Lohse, M. J., Pozzan, T., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000134629.84732.11 · Cited by 384
Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6286 · Cited by 376
Physiological Substrates of cAMP-Dependent Protein Kinase
Shabb, J. B. (2001) · Chemical Reviews · doi:10.1021/cr000236l · Cited by 373
Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance
Sahu, A. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2003.10.001 · Cited by 355
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1053 · Cited by 325
Self-citationHouslay, M. D., Baillie, G. S., & Maurice, D. H. (2007) · Circulation Research · doi:10.1161/01.res.0000261934.56938.38 · Cited by 317
Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action
Francis, S. H., & Corbin, J. D. (1999) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369991239213 · Cited by 305
Mobilisation of triacylglycerol stores
Gibbons, G. F., Islam, K., & Pease, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00182-1 · Cited by 297
Metabolism of lipids in human white adipocyte
Large, V, Peroni, O., Letexier, D., Ray, H., & Beylot, M. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70121-0 · Cited by 275
Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney
Dousa, T. P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00233.x · Cited by 274
Corbin, J. D., Turko, I. V., Beasley, A., & Francis, S. H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01297.x · Cited by 268
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
Mehats, C., Andersen, C. B., Filopanti, M., Jin, S.-L. C., & Conti, M. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00523-9 · Cited by 257
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
Giorgino, F., Laviola, L., & Eriksson, J. W. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01385.x · Cited by 230
Nanoscale Surveillance of the Brain by Microglia via cAMP-Regulated Filopodia
Bernier, L.-P., Bohlen, C. J., York, E. M., Choi, H. B., Kamyabi, A., Dissing-Olesen, L., Hefendehl, J. K., Collins, H. Y., Stevens, B., Barres, B. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.010 · Cited by 211
Lundgren, M., Burén, J., Ruge, T., Myrnäs, T., & Eriksson, J. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031157 · Cited by 163
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
Kolb, M., Crestani, B., & Maher, T. M. (2023) · European Respiratory Review · doi:10.1183/16000617.0206-2022 · Cited by 85
Burgeiro, A., Fuhrmann, A., Cherian, S., Espinoza, D., Jarak, I., Carvalho, R. A., Loureiro, M., Patrício, M., Antunes, M., & Carvalho, E. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00384.2015 · Cited by 76
McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
“Insulin’s suppressive effect on catecholamine-induced lipolysis has been shown to involve activation of cAMP phosphodiesterase (27, 35), resulting in reduced cAMP levels, and dephosphorylation of hormone-sensitive lipase via activation of a protein phosphatase (36).”
BackgroundFacchinetti, F., Appetecchia, M., Aragona, C., Bevilacqua, A., Bezerra Espinola, M. S., Bizzarri, M., D’Anna, R., Dewailly, D., Diamanti-Kandarakis, E., Hernández Marín, I., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1737675 · Cited by 63
Cong, L., Chen, K., Li, J., Gao, P., Li, Q., Mi, S., Wu, X., & Zhao, A. Z. (2007) · Biochemical Journal · doi:10.1042/bj20061478 · Cited by 62
Jönsson, C., Castor Batista, A. P., Kjølhede, P., & Strålfors, P. (2019) · Biochemical Journal · doi:10.1042/bcj20190594 · Cited by 34
Schmidt, M., Cattani-Cavalieri, I., Nuñez, F. J., & Ostrom, R. S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.05.002 · Cited by 30
Metadata
- Authors
- Degerman, E., Belfrage, P., & Manganiello, V. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-03
- Volume
- 272
- Issue
- 11
- Pages
- 6823-6826
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035690299
- Cited by
- 428
- References
- 31
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.